Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on September 16, 2014, 11:51:06 am

Title: New Hep C Meds: AbbVie’s 3D Combo
Post by: Hep Editors on September 16, 2014, 11:51:06 am
In an ongoing trial consisting of people with genotype 1 of hep C who are coinfected with HIV, 93.5% have achieved a sustained virologic response (a.k.a “cure”) within 12 weeks on this new fixed-dose combo. The 24-week group is a bit further behind in the process, but so far, 96.9% have reached an SVR, with 8 weeks of therapy left.

For more information: http://www.hepmag.com/articles/3D_coinfection_TURQUOISE_2501_26176.shtml